FIELD: biotechnology.
SUBSTANCE: invention relates to a method for producing recombinant CAS13A-nuclease free of bacterial endotoxins, suitable for use in the CRISPR/Cas system.
EFFECT: producing a purified recombinant Cas13a-nuclease protein with functional collateral RNA activity, in a technologically simple way.
14 cl, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PRODUCING AND PURIFYING FUNCTIONALLY ACTIVE RECOMBINANT NSP1 SARS-CoV-2 PROTEIN AND METHOD OF IDENTIFYING POTENTIAL ANTI-COVID-19 DRUG COMPOUNDS AIMED AT INHIBITING NSP1 | 2021 |
|
RU2822761C2 |
| METHOD OF PRODUCING A RECOMBINANT NUCLEASE CAS ESSENTIALLY FREE OF BACTERIAL ENDOTOXINS, THE PREPARATION OBTAINED BY THIS METHOD AND CONTAINING A KIT FOR USE IN A CRISPR/Cas SYSTEM | 2019 |
|
RU2707542C1 |
| NUCLEASE Cpf1 FROM BACTERIUM RUMINOCOCCUS BROMII, DNA MOLECULE OR RNA CODING NUCLEASE, VECTOR CONTAINING SAID DNA MOLECULE, CRISPR/Cpf1 SYSTEM CONTAINING SAID NUCLEASE AND GUIDE RNA, HOST CELL FOR PRODUCING NUCLEASE Cpf1, METHOD OF PRODUCING NUCLEASE Cpf1 AND USE THEREOF | 2022 |
|
RU2816876C1 |
| RECOMBINANT PLASMID DNA PCSBRZ4M ENCODING A POLYPEPTIDE WITH BRAZZEIN SWEET PROTEIN PROPERTIES AND A RECOMBINANT E. COLI STRAIN PRODUCING A POLYPEPTIDE WITH BRAZZEIN SWEET PROTEIN PROPERTIES | 2022 |
|
RU2799530C1 |
| METHOD OF PRODUCING RECOMBINANT BRUCELLOSIS PROTEIN rLptD | 2023 |
|
RU2815099C1 |
| RECOMBINANT PLASMID DNA pSNCA-C-3XFLAG-2XST-DONOR PROVIDING STABLE DOXYCYCLINE-DRIVEN EXPRESSION OF ALPHA-SYNUCLEIN CHIMERIC PROTEIN IN HUMAN CELL CULTURES | 2022 |
|
RU2795156C1 |
| ESCHERICHIA COLI BL21(DE3)PLYSS/PET15B-HISCPF1 STRAIN: PRODUCER OF RNA-GUIDED ENDONUCLEASE CRISPR/CPF1 | 2021 |
|
RU2774120C1 |
| METHOD OF OBTAINING RECOMBINANT ANTIGEN MBP_RBD_6HIS OF SARS-CoV-2 VIRUS WITH C-TERMINAL AFFINITY TAG 6XHIS-TAG, INTENDED FOR USE AS COMPONENT OF REAGENT KIT FOR COVID-19 SERODIAGNOSTICS | 2023 |
|
RU2813324C1 |
| NEW COMPACT TYPE II CAS9 NUCLEASE FROM ANOXYBACILLUS FLAVITHERMUS | 2020 |
|
RU2749307C1 |
| METHOD FOR OBTAINING OF RECOMBINANT PEPTIDOGLYCAN-ASSOCIATED LIPOPROTEIN (PAL) LEGIONELLA PNEUMOPHILA | 2016 |
|
RU2634385C1 |
